Understanding barriers to diabetes self-care is the first step in facilitating providers to identify their role in enabling patients to

Diabetic adults using same-day medical scheduling to manage their care fared no better and, in some aspects, saw their condition worsen, compared with those who

Treatment with the glitazone class of diabetes drugs leads to a “modest” increase in the risk of diabetic macular edema (DME)-a common complication that can lead to

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of

A new study has uncovered evidence that pregnant women with periodontal (gum) disease face an increased risk of developing gestational diabetes even if they

An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to

Prior research has linked low birth weights to the development of diabetes later in life. Now, new findings suggest that this is due to both poor growth as a fetus and to

Effects of Exenatide versus Sitagliptin on Postprandial Glucose, Insulin, and Glucagon Secretion, Gastric Emptying, and Caloric Intake: A Randomized, Crossover Study

A recent piece of research has found that persons who get less than 6 hours of sleep each night have a higher risk of developing pre-diabetes

We do a fasting and it looks good, we do a 2 hour glucose test and it is fine but then the A1c comes back at 7%: does the patient have diabetes or not? Randie R. Little, Associate Professor University of Missouri, Director Diabetes Diagnostic Laboratory, says we could be …